Search
for
Sort by
Research 391–420 of 1000+
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Pharmacology of anabolic steroids
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Estrogens and aging skin
- The role of androgen and androgen receptor in skin-related disorders
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Androgens and androgen receptor action in skin and hair follicles
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Acne and Systemic Disease
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Androgens and hair loss
- The therapeutic use of androgens in women
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Novel agents for the treatment of alopecia
- Does a male polycystic ovarian syndrome equivalent exist?
- Androgen treatment of postmenopausal women